Connect with us

Health

Advocate General questions the basis of EU wastewater rules

SHARE:

Published

on

We use your sign-up to provide content in ways you've consented to and to improve our understanding of you. You can unsubscribe at any time.

Advocate General Juliane Kokott has published her opinion calling on the EU’s top court to invalidate provisions in the Urban Wastewater Treatment Directive requiring pharmaceutical and cosmetics companies to fund at least 80% of the cost of removing micropollutants from urban wastewater.

“Today’s opinion strengthens the case for stopping the clock on this Directive to avoid consequences for the availability of medicines for patients,” said Director General of Medicines for Europe, Adrian van den Hoven. “The Commission should use this opportunity to properly review the EPR scheme before companies are forced to make decisions that could affect medicine supply or health security.”

The opinion, issued in response to a Polish challenge to the Directive, is not binding on the Court of Justice of the European Union, but it appears to support criticisms that industry has long made about the evidence and proportionality underpinning the extended producer responsibility (EPR) scheme.

Generic and biosimilar companies say those concerns are already affecting investment decisions. Manufacturers must plan production years ahead.

Share this article:

Share this:
Guest Contributor - Opinion

Opinions expressed are purely those of the author and not endorsed by EU Reporter. The article was unsolicited by EU Reporter, and the author guarantees the truthfulness of the contents of the article. No payment was made by EU Reporter to the author

EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.
Advertisement

Trending